Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | genetic association 0.13 (overall 0.11) | 0.13 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | reachable by antibody | 0.45 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 4 Parkinson's papers of 151 | 0.79 |
| pathways Reactome | in no curated pathway | 0.00 |
No case: the score is under the bar. Receipt 2404
Sealed predictions
- GRID2 in dopamine neurons, braak+0.75 (p 0.021) → +0.14 (p 0.714)receipt 2410
Swarm cases
receipt 2410: GRID2 in dopamine neurons, braak
- power
- full sample +0.40 (p 0.103, n 18), 95% CI -0.09 to +0.73. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.39 (p 0.114, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.37 (p 0.132, n 18). could be the mix.
- skeptic
- leave-one-out range +0.32 to +0.60, sign flips 0; without severely affected donors +0.40 (p 0.103, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for GRID2 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts